- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
May 12, 2022Robins Kaplan Practice Group, Attorney Recognized in Elite Trial Lawyers Awards
-
May 9, 2022Six Partners Recognized as “IP Stars” by Managing Intellectual Property
-
May 4, 2022Robins Kaplan LLP Relocates Silicon Valley Office
-
May 23, 2022IPWatchdog Patent Litigation Masters™ 2022
-
May 24, 2022Intellectual Property and Innovation Summit, USA
-
May 26, 2022Democracy’s Last Line of Defense
-
May 5, 2022Antitrust Law As A Tool Against Privacy Abuses
-
First QuarterANDA Litigation Settlements
-
First QuarterNew ANDA Cases
-
May 19, 2022Inflation-Battered Retailers Spur Vast Market Selloff
-
May 18, 2022Connecticut Becomes Fifth US State to Pass Comprehensive Consumer Privacy Law
-
May 18, 2022Allianz Unit Pleads Guilty, Fined $6B Over Securities Fraud
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Obtained $589 Million Settlement in Landmark National Opioid Litigation on Behalf of Tribal Nations
A Historic First in Tribal Government Litigation
March 2022
In Re: National Prescription Opiate Litigation, 17-cv-2804 (N.D. Ohio)
Robins Kaplan represented 28 Tribal Nations asserting that the manufacturers of prescription opioids grossly misrepresented the risks of long-term use of those drugs for persons with chronic pain, and distributors failed to properly monitor suspicious orders of those prescription drugs, all of which contributed to the current opioid epidemic.
The firm, as part of the Tribal Leadership Committee, secured an initial total settlement of $589 Million on behalf of all federally recognized Tribes.
The firm secured a $439 million settlement of the national opioid litigation claims by Tribes brought against AmerisourceBergen Corp., McKesson Corp., Cardinal Health, Inc. (“Distributors”).
The firm also secured a $150 million settlement of the national opioid litigation claims by Tribes brought against Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica, Inc. N/K/A Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc., N/K/A Janssen Pharmaceuticals, Inc. (“Janssen”).
This case and these initial settlements represent a historic first in Tribal governments litigating together to exercise their sovereignty.
Related Professionals
Holly H. Dolejsi
Partner
Deputy Chair, Mass Tort, Personal Injury and Medical Malpractice Groups
Chair, Women of Robins Kaplan Resource Group
Pronouns: she/her
Timothy Q. Purdon
Partner
Co-Chair, American Indian Law and Policy Group;
Co-Chair, Government and Internal Investigations Group;
Co-Chair, Diversity, Equity and Inclusion Committee
Brendan V. Johnson
Partner
Co-Chair, American Indian Law and Policy Group;
Co-Chair, Government and Internal Investigations Group
Member of the Executive Board
Similar Results
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.